Veiga, Nuphar
Goldsmith, Meir
Granot, Yasmin
Rosenblum, Daniel
Dammes, Niels
Kedmi, Ranit
Ramishetti, Srinivas
Peer, Dan http://orcid.org/0000-0001-8238-0673
Funding for this research was provided by:
EC | European Research Council (647410)
Article History
Received: 29 June 2018
Accepted: 2 October 2018
First Online: 29 October 2018
Competing interests
: D.P. declare financial interest in Quiet Therapeutics, ART Biosciences and SEPL pharma. The remaining authors declare no competing interests.